| Mar 27, 2025 | Outcome Of The Order |
| Mar 27, 2025 | Order 27 March |
| Mar 27, 2025 | Headnote And Keywords |
| Mar 17, 2025 | Written Submission On Request To Intervene By Zentiva |
| Mar 1, 2025 | Template Order |
| Mar 1, 2025 | Preliminary Order 1St March |
| Feb 28, 2025 | Exhibit 046 Zentiva Portugal Certificate Of Incorporation |
| Feb 28, 2025 | Exhibit 045 Zentiva K S Certificate Of Incorporation |
| Feb 28, 2025 | Exhibit 044 Novartis Ag V Stada Pi Lg Munchen I Judgment Of 4 December Case No 21 O 14559 24 |
| Feb 28, 2025 | Exhibit 043 Insulet V Menarini Upc Court Of First Instance Milan Procedural Order Of 1 October Case No Upc Cfi 380 2 |
| Feb 28, 2025 | Exhibit 042 Akzo Nobel Chemicals And Akcros Chemicals V Commission Cjeu 14 September Case C 550 07 P |
| Feb 28, 2025 | Exhibit 041 Artegodan Gmbh V European Commission Cjeu Third Chamber 19 April Case C 221 10 P |
| Feb 28, 2025 | Exhibit 040 European Ferries And Diputacion Foral De Vizcaya V Commission Cjeu 1 June Joined Cases C 442 03 P And C |
| Feb 28, 2025 | Exhibit 039 Director Of The Spanish Agency Of Medicines And Medical Devices N D Resolution On The Termination Of The Mar |
| Feb 28, 2025 | Exhibit 038 Director Of The Spanish Agency Of Medicines And Medical Devices N D Resolution On The Termination Of The Mark |
| Feb 28, 2025 | Exhibit 037 Ce Decision Revoking Decision C 3252 |
| Feb 28, 2025 | Exhibit 036 Commission V Pharmaceutical Works Polpharma S A Et Al Cjeu 16 March Joined Cases C 438 21 P To C 440 21 |
| Feb 28, 2025 | Exhibit 035 Stadapharm V Novartis And Accord Healthcare Upc Court Of First Instance Milan Preliminary Order Of 3 February |
| Feb 28, 2025 | Exhibit 034 Novartis Ag V Aliud Pharma Lg Munchen I Judgment Of 4 December Case No 21 O 14559 24 |
| Feb 28, 2025 | Exhibit 033 Mediatek V Daedalus Prime Llc Upc Court Of Appeal Order Of 8 January Case No Upc Coa 621 |
| Feb 28, 2025 | Exhibit 032 Dolby V Hp Deutschland Upc Court Of First Instance Dusseldorf Judgment Of 26 June Case No Upc Cfi 457 20 |
| Feb 28, 2025 | Exhibit 031 Nec V Tcl Upc Court Of First Instance Munich Order Of 2 October Case No Upc Cfi 487 |
| Feb 28, 2025 | Exhibit 030 Seoul Viosys V Expert E Commerce Upc Court Of First Instance Dusseldorf Judgment Of 22 April Case No Upc |
| Feb 28, 2025 | Exhibit 029 Swarco V Strabag Upc Court Of First Instance Vienna Judgment Of 30 July Case No Upc Cfi 33 |
| Feb 28, 2025 | Exhibit 028 Insulet Menarini Upc Court Of First Instance Milan Procedural Order Of 23 December Case No Upc Cfi 380 2 |
| Feb 28, 2025 | Exhibit 027 Ocado V Autostore Upc Court Of Appeal Order Of 10 January Case No Upc Coa 404 |
| Feb 28, 2025 | Exhibit 026 Directive 83 Ec |
| Feb 28, 2025 | Exhibit 025 Regulation Ec No 726 |
| Feb 28, 2025 | Exhibit 024 Summary Of Product Characteristics Nilotinib Zentiva Ro |
| Feb 28, 2025 | Exhibit 023 Summary Of Product Characteristics Nilotinib Zentiva Pt |
| Feb 28, 2025 | Exhibit 022 Summary Of Product Characteristics Nilotinib Zentiva Lv |
| Feb 28, 2025 | Exhibit 021 Summary Of Product Characteristics Nilotinib Zentiva Lt |
| Feb 28, 2025 | Exhibit 020 Summary Of Product Characteristics Nilotinib Zentiva Ee |
| Feb 28, 2025 | Exhibit 019 Summary Of Product Characteristics Nilotinib Zentiva Bg |
| Feb 28, 2025 | Exhibit 018 Action Brought On 21 October Novartis Europharm V Commission Case T 547 24 C 396 |
| Feb 28, 2025 | Exhibit 017 Novartis Second Offer For A Non Exclusive Licensee From |
| Feb 28, 2025 | Exhibit 016 Novartis First For A Non Exclusive Licensee From |
| Feb 28, 2025 | Exhibit 015 Marketing Authorization Lituania 150 Mg And 200 Mg |
| Feb 28, 2025 | Exhibit 014 Marketing Authorization Romania 200 Mg |
| Feb 28, 2025 | Exhibit 013 Marketing Authorization Romania 150 Mg |
| Feb 28, 2025 | Exhibit 012 Marketing Authorization Bulgaria 150 Mg |
| Feb 28, 2025 | Exhibit 011 Marketing Authorization Bulgaria 200 Mg |
| Feb 28, 2025 | Exhibit 010 Marketing Authorization Portugese 50 Mg |
| Feb 28, 2025 | Exhibit 009 Marketing Authorization Portugese 150 Mg |
| Feb 28, 2025 | Exhibit 008 Marketing Authorization Portugese 200 Mg |
| Feb 28, 2025 | Exhibit 007 Marketing Authorization Estonian 200 Mg |
| Feb 28, 2025 | Exhibit 006 Marketing Authorization Estonian 150 Mg |
| Feb 28, 2025 | Exhibit 005 Marketing Authorization Latvia 200 Mg |
| Feb 28, 2025 | Exhibit 004 Marketing Authorization Latvia 150 Mg |
| Feb 28, 2025 | Exhibit 003 Smpc Nilotinib Accord Healthcare |
| Feb 28, 2025 | Exhibit 002 Smpc Tasigna Novartis |
| Feb 28, 2025 | Exhibit 001 EP2501384B2 |
| Feb 28, 2025 | Application |